Transgene Biotek Ltd
Transgene Biotek Ltd Share Price Today: Live Updates & Key Insights
Get insights on Transgene Biotek Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Transgene Biotek Ltd Share Price Chart
Transgene Biotek Ltd Fundamentals
Traded Volume: null
Market Cap(Cr): null
Avg Traded Price null
1 Year return %
Upper Circuit null
Lower Circuit null
P/E TTM 0.00
P/B Ratio 0.00
Traded Value(Cr) null
EPS TTM NaN
Book value NaN
Dividend null%
Transgene Biotek Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Transgene Biotek Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Transgene Biotek Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W null%
1M null%
3M null%
1Y null%
YTD null%
Transgene Biotek Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Transgene Biotek Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday null
Day Before Yesterday null
1W Avg null
1M Avg null
3M Avg null
Transgene Biotek Ltd Technical Details
Transgene Biotek Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 null
Support 2 null
Support 3 null
Pivot Point : null
Resistance 1 null
Resistance 2 null
Resistance 3 null
Transgene Biotek Ltd Corporate Actions
Transgene Biotek Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Transgene Biotek Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by null
Bonus
No Bonus has been declared by null
Splits
No Split has been declared by null
Others
Rights No Rights has been declared by null
Transgene Biotek Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Transgene Biotek Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Transgene Biotek Ltd's relative performance and valuation against major competitors.
Stock Name Deccan Health Care Ltd ₹16.35 (-3.54%) M. Cap (Cr) 0.38 1 Yr Return (%) -37.90% P/E (TTM) 35.55 PB Ratio 0.36
Stock Name GKB Ophthalmics Ltd ₹65.99 (+1.51%) M. Cap (Cr) 0.33 1 Yr Return (%) -38.01% P/E (TTM) -4.26 PB Ratio 0.57
Stock Name Bandaram Pharma Packtech Ltd ₹26.75 (+1.44%) M. Cap (Cr) 0.32 1 Yr Return (%) -44.28% P/E (TTM) 38.74 PB Ratio 2.54
Stock Name Transgene Biotek Ltd ₹3.40 (+0.30%) M. Cap (Cr) 0.26 1 Yr Return (%) -50.37% P/E (TTM) -20.33 PB Ratio 2.46
Stock Name Family Care Hospitals Ltd ₹3.86 (-4.46%) M. Cap (Cr) 0.21 1 Yr Return (%) -47.98% P/E (TTM) -3.25 PB Ratio 0.36
Stock Name Vanta Bioscience Ltd ₹27.60 (-0.33%) M. Cap (Cr) 0.20 1 Yr Return (%) -48.12% P/E (TTM) -8.48 PB Ratio 1.41
Stock Name Gian Lifecare Ltd ₹12.47 (+3.31%) M. Cap (Cr) 0.13 1 Yr Return (%) -40.62% P/E (TTM) -169.80 PB Ratio 1.24
Transgene Biotek Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Transgene Biotek Ltd, across its operating activities, investing activities, and financing activities.
Transgene Biotek Ltd Shareholding Pattern
This shows the ownership breakdown of Transgene Biotek Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter null%
Public null%
Other Institutions null%
FII null%
Mutual Funds null%
About Transgene Biotek Ltd
Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India. Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc. The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively. Transgene Biotek`s products are exported to Africa, Russia, China, Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility costing Rs. 30 crore at the Anrich Industrial Area, Bollaram. TBL is working of four new plants comprising of Oral deliver of proteins and peptides; DNA vaccines; fusion proteins and bio therapeutics. The new project is funded through preferential offer to Batterymarch Financial Management USA and Other Financial Institutions (FIs). The Company absorbed the transfer of technology from RBB Inc, USA for the manufacture and marketing of Erythropoietin during year 2003. The Scheme of Arrangement for Amalgamation of M/S Saket Biotechnologies Private Limited (SBPL) with the Company was implemented and made effective on 7th February, 2005. In terms of the said Scheme of Amalgamation, 60,60,000 Equity Shares were allotted to the Sharesholders of M/S Saket Biotechnologies Private limited on 27 April 2005. In 2012-13, the Company started the commercial production of Omega-3 DHA (Docosahexaenoic Acid) . It formulated the molecule belonging to a very large global pharma company for undergoing studies at its own chosen facilities in USA during year 2020-21. Transgene has been developing novel oral and nasal formulations for the delivery of various protein and peptide-based biologicals through oral and intra-nasal routes. Transgene is focused on developing novel therapies in the areas of Oncology, Auto-Immune diseases and new drug delivery technologies, that have the potential to substantially improve the quality of life of patients in areas of unmet medical need.
Independent Director
Sujana Kadiam
Registered office Plot No 69 & 70 IDA Bollaram, null, Sangareddy, Telangana, 502325
FAX :null
Background
Incorporation Year 1990
Face Value ₹10.00
Market Lot 1
FAQs on Transgene Biotek Ltd
How to buy Transgene Biotek Ltd shares on NSE?
To buy Transgene Biotek Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Transgene Biotek Ltd share price today?
The Transgene Biotek Ltd share price on NSE is ₹N/A today.
What is the market cap of Transgene Biotek Ltd on NSE?
The company has a market capitalization of ₹N/A.
What is the PE & PB ratio of Transgene Biotek Ltd?
PE is N/A and PB is N/A.
What is the 52 Week High and Low of Transgene Biotek Ltd shares?
Transgene Biotek Ltd stock price high: ₹N/A Transgene Biotek Ltd stock price low: ₹N/A.